EURUSD Bid: --
USDJPY Bid: --
GBPUSD Bid: --
USDCHF Bid: --
AUDUSD Bid: --
USDCAD Bid: --
NZDUSD Bid: --
EURGBP Bid: --
GBPJPY Bid: --
WTI Bid: --
BRENT Bid: --
XAUUSD Bid: --
XAGUSD Bid: --
SPX500 Bid: --
DAX40 Bid: --
US30 Bid: --
JPN225 Bid: --
NAS100 Bid: --
UK100 Bid: --
BTCUSD Bid: --
ETHUSD Bid: --
LTCUSD Bid: --
XRPUSD Bid: --
EURUSD Bid: --
USDJPY Bid: --
GBPUSD Bid: --
USDCHF Bid: --
AUDUSD Bid: --
USDCAD Bid: --
NZDUSD Bid: --
EURGBP Bid: --
GBPJPY Bid: --
WTI Bid: --
BRENT Bid: --
XAUUSD Bid: --
XAGUSD Bid: --
SPX500 Bid: --
DAX40 Bid: --
US30 Bid: --
JPN225 Bid: --
NAS100 Bid: --
UK100 Bid: --
BTCUSD Bid: --
ETHUSD Bid: --
LTCUSD Bid: --
XRPUSD Bid: --

iFOREX Shares Frozen in Place Three Weeks After London Debut

Posted: 18th Mar 2026

It has been two weeks since anyone moved the needle on iFOREX Financial Trading Holdings on the London Stock Exchange, and the silence is becoming hard to ignore.

The CFD broker, which listed on the LSE's Main Market on February 25 after an eight-month delay, is sitting at around 207 pence per share, roughly 6% above its 195p offer price, but that figure tells investors almost nothing useful.

A Free Float That's More Like a Free Freeze

The arithmetic here is straightforward. When iFOREX priced its IPO at 195 pence, it issued 4,487,179 new ordinary shares, representing just 20.2% of its total share capital. No existing shareholders sold down their stakes. The raise totaled £8.75 million against a company valuation of roughly £43.3 million.

That leaves only one-fifth of the company available to trade, and even within that slice, institutional investors who participated in the placing are typically under informal expectations not to flip quickly.

Founder Eyal Carmon, who holds 58.91% of the company post-listing and is selling nothing, has agreed to a 12-month lock-up, as have the company's directors and senior managers. The result is a stock with so little tradeable supply that a single motivated buyer or seller could move the price by a meaningful percentage, which also means most cautious investors simply won't touch it.

The Debut Pop That Quickly Went Quiet

The first day of trading looked more promising. Shares opened above the offer price and quickly moved roughly 6% higher, driven by a small burst of post-IPO enthusiasm. CEO Itai Sadeh called the listing "a pivotal moment in iFOREX's evolution," and noted that the oversubscribed placing "reflects investor confidence in our strategy, solid fundamentals and scalable operating model."

But that momentum evaporated fast. Within days, volume dried up entirely. By the first week of March, the shares were effectively frozen. No analysts cover the stock. No major institutional holders have disclosed positions. And with a market cap of just over £46 million at current prices, the company sits well below the threshold that would attract meaningful attention from UK equity fund managers.

Financials That Didn't Exactly Build Excitement

The numbers published ahead of the listing didn't give investors much to work with, either. iFOREX reported 2025 revenue of $48.8 million, slightly below the $50.1 million recorded in 2024. Adjusted EBITDA for the year is expected to come in at around $4 million, down sharply from $9.7 million the previous year. Net profit for the first half of 2025 was just over $1.2 million, a 63.5% drop compared with the same period in 2024.

The company attributed some of the weakness to low market volatility during the third quarter and the prolonged uncertainty surrounding its IPO timeline. It also acknowledged in the prospectus that a "short-term revenue initiative" it tried during that difficult stretch "was ineffective and... promptly reversed." The prospectus added that "the Group has positive momentum into FY26," though that characterization comes from the company itself.

One structural concern that analysts flagged ahead of the listing remains unresolved: over 95% of iFOREX's revenue comes from its British Virgin Islands-regulated offshore entity, while its Cyprus-registered firm contributes the rest.

The broker operates primarily in Japan, India, and the Middle East, but holds no license in any of those markets, relying instead on reverse solicitation arrangements that regulators in those jurisdictions have increasingly questioned.

The eToro Contrast

The comparison to eToro is instructive, even if the two companies are playing in different leagues. When eToro finally completed its long-awaited US IPO last year, it came in at a $4 billion-plus valuation, was 10 times oversubscribed, and attracted significant institutional interest off the back of a crypto trading boom and surging retail engagement.

The stock has had its own struggles since listing. eToro posted record 2025 revenue of $868 million yet its shares have faced pressure amid broader market turbulence, but at least it has a market. Trades happen every day. Analysts write about it. Investors argue about it.

iFOREX, by contrast, completed an IPO more comparable in scale to a small regional listing. It raised less than $11 million in gross proceeds and trades on a market where the broader IPO pipeline has been sputtering for years.

The London Stock Exchange has been losing ground to New York as a listing destination for some time, and smaller listings on its Main Market often disappear from the radar within weeks of debut.

For iFOREX shares to start moving meaningfully, a few things would need to happen. The company would need to deliver financial results that exceed the underwhelming 2025 figures. It would need to secure at least one of the regulatory licenses it's targeting in Australia, the UAE, Malaysia, Chile, or the UK - progress on any of those fronts could serve as a genuine catalyst. And it would need to attract a market maker or analyst willing to put the stock in front of investors who weren't part of the original placing.

This article was written by Damian Chmiel at www.financemagnates.com.

Source: Finance Magnates

Follow us on
Website Managed by BuiltByGo
Disclaimer: The information provided on FX Axe is for educational and informational purposes only and should not be construed as financial advice. Trading Foreign Exchange (FX), Contracts for Difference (CFDs), and other leveraged financial products involves a high level of risk and may not be suitable for all investors. Leverage can work both to your advantage and disadvantage, and as a result, you may lose more than your initial investment. Before deciding to trade FX, CFDs, or any other financial instrument, you should carefully consider your investment objectives, level of experience, and risk tolerance. You should not invest money that you cannot afford to lose. It is strongly advised that you seek independent financial advice if you have any doubts. FX Axe does not provide investment, tax, legal, or financial advice of any kind. We may receive compensation from brokers and partners featured on this website, but such relationships do not influence our reviews or recommendations. All reviews are based on our own opinions and research and should not be interpreted as endorsements or guarantees of any service. Past performance is not indicative of future results. The trading of FX and CFDs carries a significant risk of loss. By using this website, you acknowledge that FX Axe bears no responsibility for any losses you may incur from your trading activities or reliance on information provided here.

Affiliate Disclosure: Some of the links and references on FX Axe may relate to third-party brokers or service providers. In certain cases, we may receive compensation if you choose to engage with these providers through our website. This helps support the ongoing operation of the site and allows us to continue publishing content at no direct cost to our readers. Our content is created with the aim of being informative and useful. While commercial relationships may exist, we strive to ensure that the information presented remains objective and based on our own research and perspective.
cross